Literature DB >> 10343258

Lobe-specific extent of systematic lymph node dissection for non-small cell lung carcinomas according to a retrospective study of metastasis and prognosis.

H Asamura1, H Nakayama, H Kondo, R Tsuchiya, T Naruke.   

Abstract

BACKGROUND: Complete lymphadenectomy of the mediastinum is advised for patients with lung cancer to provide prognostic information and possible survival benefit. The proper extent of dissection should be further defined.
METHOD: The lymphatic metastatic patterns according to the primary site and prognoses were retrospectively analyzed in 166 patients with non-small cell carcinoma who underwent at least lobectomy with hilar and mediastinal lymphadenectomy. All patients had histologically proven mediastinal metastasis (pN2).
RESULTS: Among 54 right upper lobe tumors the most common site of metastasis was the lower pretracheal station (74%), whereas metastases to the subcarinal station were seen only in 13%. Among 8 patients with right middle lobe tumors and 41 patients with right lower lobe tumors, both superior mediastinal and subcarinal stations were involved. The 34 left upper segment tumors metastasized to the aorticopulmonary window most commonly (71%) and to the subcarina only in 12% of cases. Inversely, the 10 left lingular tumors metastasized to the subcarina most commonly (50%) and to the aorticopulmonary window only in 20% of cases. Among 44 left lower lobe tumors the subcarinal station was most common for metastasis (58%), with infrequent metastases to the aorticopulmonary window. The 5-year survival for all 166 patients was 35%. Patients with single-station and single-node metastases had a significantly better prognosis than those with more extensive metastases. Right lower lobe tumors with superior mediastinal metastasis carried a particularly poor 5-year survival of only 4.1%. COMMENT: Subcarinal lymphadenectomy is not always necessary for tumors of the right upper lobe and left upper segment. For tumors of other lobes both superior mediastinal dissection and subcarinal dissection are advised. However, superior mediastinal metastasis should be recognized as an indicator of poor prognosis in tumors of both lower lobes.

Entities:  

Mesh:

Year:  1999        PMID: 10343258     DOI: 10.1016/s0022-5223(99)70246-1

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  55 in total

Review 1.  Last-intercalated node and direct lymphatic drainage into the thoracic duct from the thoracoabdominal viscera.

Authors:  Gen Murakami; Masato Abe; Tomio Abe
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2002-03

2.  Mediastinal lymphatic drainage from pulmonary lobe based on CT observations of histoplasmosis: implications for minimal N2 disease of non-small-cell lung cancer.

Authors:  Koji Takahashi; William Stanford; Edwin Van Beek; Brad Thompson; Brian Mullan; Yutaka Sato
Journal:  Radiat Med       Date:  2007-10-26

3.  Therapeutic value of lymph node dissection for right middle lobe non-small-cell lung cancer.

Authors:  Hiroaki Kuroda; Yukinori Sakao; Mingyon Mun; Noriko Motoi; Yuichi Ishikawa; Ken Nakagawa; Yasushi Yatabe; Sakae Okumura
Journal:  J Thorac Dis       Date:  2016-05       Impact factor: 2.895

4.  Proposal of new nodal classifications for non-small-cell lung cancer based on the number and ratio of metastatic lymph nodes.

Authors:  Haruhisa Matsuguma; Izumi Oki; Rie Nakahara; Norihisa Ohata; Seiji Igarashi; Kiyoshi Mori; Shunsuke Endo; Kohei Yokoi
Journal:  Eur J Cardiothorac Surg       Date:  2012-01       Impact factor: 4.191

5.  Has lobe-specific nodal dissection for early-stage non-small lung cancer already become standard treatment?

Authors:  Tomohiro Maniwa; Ken Kodama
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

6.  From anatomy to lung cancer: questioning lobe-specific mediastinal lymphadenectomy reliability.

Authors:  Marc Riquet; Ciprian Pricopi; Alex Arame; Françoise Le Pimpec Barthes
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

7.  A lobe-specific lymphadenectomy protocol for solitary pulmonary nodules in non-small cell lung cancer.

Authors:  Xue-Ning Yang; Ze-Rui Zhao; Wen-Zhao Zhong; Qiang Nie; Ri-Qiang Liao; Song Dong
Journal:  Chin J Cancer Res       Date:  2015-12       Impact factor: 5.087

8.  Impact of main bronchial lymph node involvement in pathological T1-2N1M0 non-small-cell lung cancer: multi-institutional survey by the Japan National Hospital Study Group for Lung Cancer.

Authors:  Hajime Maeda; Shimao Fukai; Akihide Matsumura; Osamu Kawashima; Takehiro Watanabe; Takeshi Yamanda; Kan Okabayashi; Yuka Fujita; Atsuhisa Tamura; Masaaki Kawahara
Journal:  Gen Thorac Cardiovasc Surg       Date:  2009-11-12

9.  Changes in hemodynamics in patients who underwent extended mediastinal lymphadenectomy through median sternotomy for primary lung cancer.

Authors:  Tomomi Hirata; Kiyoshi Koizumi; Shigeo Tanaka
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2003-05

10.  Heterogeneity of the EGFR mutation status between the primary tumor and metastatic lymph node and the sensitivity to EGFR tyrosine kinase inhibitor in non-small cell lung cancer.

Authors:  Katsuhiko Shimizu; Takuro Yukawa; Yuji Hirami; Riki Okita; Shinsuke Saisho; Ai Maeda; Koichiro Yasuda; Masao Nakata
Journal:  Target Oncol       Date:  2012-12-05       Impact factor: 4.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.